Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Current Leases (2023 - 2025)

CG Oncology's Current Leases history spans 3 years, with the latest figure at $915000.0 for Q4 2025.

  • For Q4 2025, Current Leases rose 391.94% year-over-year to $915000.0; the TTM value through Dec 2025 reached $915000.0, up 391.94%, while the annual FY2025 figure was $915000.0, 391.94% up from the prior year.
  • Current Leases reached $915000.0 in Q4 2025 per CGON's latest filing, roughly flat from $912000.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $915000.0 in Q4 2025 to a low of $186000.0 in Q4 2024.
  • Average Current Leases over 3 years is $383888.9, with a median of $237000.0 recorded in 2024.
  • Peak YoY movement for Current Leases: decreased 14.29% in 2024, then skyrocketed 391.94% in 2025.
  • A 3-year view of Current Leases shows it stood at $217000.0 in 2023, then dropped by 14.29% to $186000.0 in 2024, then surged by 391.94% to $915000.0 in 2025.
  • Per Business Quant, the three most recent readings for CGON's Current Leases are $915000.0 (Q4 2025), $912000.0 (Q3 2025), and $288000.0 (Q2 2025).